Ignite Creation Date:
2024-05-06 @ 4:32 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05012228
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2021-08-03
Brief Title:
Molecular Mechanisms of FibrillinLTBP Superfamily in Renal Fibrosis and Cardiorenal Syndrome
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Molecular Mechanisms of FibrillinLTBP Superfamily in Renal Fibrosis and Cardiorenal
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This project is to understand the LTBP4 expression in human renal fibrotic tissues The investigators will exam major location of LTBP4 expression and check any similar or discrepancy in renal fibrosis with different etiologies
Detailed Description:
The investigators will obtain the residual renal tissues with different etiologies and check the expression of LTBP4 The location and quantitation of LTBP4 in renal tissues will be checked It will be great to understand the association between the severity of fibrosis and the expression of LTBP4 and other matrix proteins
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None